Results

Total Results: 1,892 records

Showing results for "drugs".

181. Opioids AHRQ Works: Building Bridges Between Research and Practice (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/topics/impact-opioid-final.pdf
     November 01, 2018 - recovery services  Better data  Better research  Better targeting of overdose-reversing drugs … statistics from 32 HCUP participating States on hospital stays that involve alcohol, opioids, and other drugs

182. Blood Thinner Pills: Your Guide to Using Them Safely (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/diagnosis-treatment/treatments/btpills/btpills.pdf
     September 01, 2015 - Blood thinner drugs work well when they are used correctly. … When you visit your doctor, bring a list of current medicines, over-the-counter drugs—such as aspirin

183. Medication Discrepancies and Potential Adverse Drug Events During Transfer of Care from Hospital to Home | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/reports/liability/neumiller.html
     August 01, 2017 - Drugs resulting in serious potential ADEs included exemestane, enoxaparin, warfarin, and sublingual nitroglycerin … Minor potential ADEs most often involved OTC agents, antacids, cholesterol lowering drugs, allergic rhinitis … agents, nonsteroidal anti-inflammatory drugs (NSAIDs), and thyroid supplements. … common medication classes involved were antibiotics, antidepressants, antipsychotics, cardiovascular drugs

184. AHRQ News Now | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/index.html
     September 09, 2025 - Stability January 7, 2025 Recent Evidence Indicates a Flourishing Market for Biosimilar Drugs

185. NICU Family Information Packet, Appendix B, Feeding Tubes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-tubes.pdf
     June 02, 2025 - ■ Consider prokinetic drugs. ■ Consider antiemetics.

186. Rural/Inner-City Residents | Agency for Healthcare Research and Quality
     www.ahrq.gov/topics/ruralinner-city-residents.html
     Topic: Rural/Inner-City Residents Rural and inner-city populations each face unique healthcare challenges. Geographic isolation, persistent shortages of healthcare providers, lower socioeconomic status and levels of educational attainment, cultural and social differences, and lack of health insurance all contribute t…

187. Care Coordination | Agency for Healthcare Research and Quality
     www.ahrq.gov/topics/care-coordination.html
     January 01, 2014 - Care Coordination Care coordination involves deliberately organizing patient care activities and sharing information among all of the participants concerned with a patient's care to achieve safer and more effective care. This means that the patient's needs and preferences are known ahead of time a…

188. CHIPRA Publications | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/chipra-publications.html
     July 01, 2015 - Paediatr Drugs 2013 Dec;15(6):441-7.

189. Reporting of Adverse Drug Events: Examination of a Hospital Incident Reporting System (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Desikan.pdf
     March 01, 2002 - DoseChecker routinely screens approximately 50 drugs that are either potentially toxic or typically … In RMEES, the drugs most frequently reported involving preventable adverse drug events were heparin, … insulin, vancomycin, and morphine (all from the top four drug classes of RMEES), while the drugs most … More than 50 percent of the preventable adverse drug events in RMEES were associated with just 14 drugs … , while no such pattern was noted for the drugs involved in PHRED events.

190. Community-Acquired Pneumonia (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/CAP-one-page.docx
     November 01, 2019 - Drugs. 2008;68(13):1841-54. PMID: 18729535. Dunbar LM, Khashab MM, Kahn JB, et al.

191. | Agency for Healthcare Research and Quality
     www.ahrq.gov/
     August 31, 2025 - Program Improving healthcare quality by providing the best available evidence on benefits and harms of drugs

192. Reducing Disparities in the Primary Prevention of Cardiovascular Disease (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/persell_cvd_disparities.pdf
     June 02, 2025 - Statin drugs decrease CVD illness and mortality in people at high risk.

193. Iowa Medicaid Uses AHRQ Research, Data to Improve Quality | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/ktcoe33.html
     October 01, 2014 - adult and pediatric psychiatrists, pediatricians, and pharmacists who specialize in behavioral health drugs

194. Adverse Drug Events occurring in U.S. Hospitals (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/adverse-drug-events.pdf
     June 02, 2025 - Adverse Drug Events occurring in U.S. Hospitals 0 10 20 30 40 50 60 70 80 Adverse Drug Events Occurring in U.S. Hospitals Adverse drug events (ADEs) are the most common nonsurgical adverse events that occur in hospitals. New data from all payers in 32 States in HCUP show characteristics of the four most frequent …

195. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIII.pdf
     August 13, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

196. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIII.pdf
     August 25, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

197. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_XIII.pdf
     January 01, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

198. | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/programs/index.html?page=1
     healthcare by synthesizing and disseminating the best available evidence on the benefits and harms of drugs

199. Appendix, Data Collection Strategy, Assessment, and Process Evaluation | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/match/appendix/app-6a.html
     July 01, 2022 - If a patient will be provided/given any medications while under our care or prescribed any new drugs

200. Appendix, Data Collection Strategy, Assessment, and Process Evaluation | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/patient-safety/settings/hospital/match/appendix/app-6a.html
     July 01, 2022 - If a patient will be provided/given any medications while under our care or prescribed any new drugs